Showing results (201-210 of 258) with videos related to
Sort By:
Pageof 26
Clinical Colorectal Cancer|September 21, 2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximabAlexios Strimpakos, George Pentheroudakis, Vassiliki Kotoula, et al.Cancer Chemotherapy and Pharmacology|May 8, 2015
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patientsAnna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, et al.Frontiers in Oncology|June 18, 2021
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?Elena Fountzilas, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.Journal of Translational Medicine|May 30, 2015
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation studyAngelos Koutras, Konstantine T Kalogeras, Ralph M Wirtz, et al.Translational Oncology|July 1, 2017
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant ChemotherapyEleni Timotheadou, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Prognostication of the high-risk WM patientEfstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, et al.Cancer Genomics & Proteomics|October 22, 2018
Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with TrastuzumabChristos Christodoulou, Georgios Oikonomopoulos, Georgia Angeliki Koliou, et al.Plos One|September 30, 2016
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesVassiliki Kotoula, Sotiris Lakis, Ioannis S Vlachos, et al.Anticancer Research|April 4, 2021
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast CancerGeorgios Rigakos, Evangelia Razis, Georgia-Angeliki Koliou, et al.Plos One|May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trialGeorge Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.Pageof 26